FR - OX40: una diana terapéutica prometedora en la dermatitis atópica moderada-grave
Saved in:
| Main Authors: | M. Zulaika-Lloret, M. Rodriguez-Troncoso, R. Ruiz-Villaverde |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Actas Dermo-Sifiliográficas |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0001731024010548 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[Translated article] RF – OX40: A Promising Therapeutic Target in Moderate-to-severe Atopic Dermatitis
by: M. Zulaika-Lloret, et al.
Published: (2025-05-01) -
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review
by: Valenzuela F, et al.
Published: (2025-05-01) -
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
by: Asaad Abdelhalim, et al.
Published: (2024-11-01) -
Perfil clínico, epidemiológico y respuesta al tratamiento, en función de la comorbilidad atópica asociada en la dermatitis atópica. Experiencia del registro BIOBADATOP
by: V. Peris-Espino, et al.
Published: (2025-04-01) -
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
by: James G. Krueger, et al.
Published: (2025-08-01)